Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
283M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
71.3M
-
Shares change
-
-3.03M
-
Total reported value, excl. options
-
$140M
-
Value change
-
-$6.33M
-
Put/Call ratio
-
1.5
-
Number of buys
-
56
-
Number of sells
-
-39
-
Price
-
$1.97
Significant Holders of Erasca, Inc. - Common Stock (ERAS) as of Q3 2023
120 filings reported holding ERAS - Erasca, Inc. - Common Stock as of Q3 2023.
Erasca, Inc. - Common Stock (ERAS) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.3M shares
of 283M outstanding shares and own 25.16% of the company stock.
Largest 10 shareholders include ARCH Venture Management, LLC (11.1M shares), Cormorant Asset Management, LP (10.8M shares), ARMISTICE CAPITAL, LLC (8.36M shares), BlackRock Inc. (7.03M shares), VANGUARD GROUP INC (5.12M shares), Artal Group S.A. (4.72M shares), PFM Health Sciences, LP (3.93M shares), INTERNATIONAL BIOTECHNOLOGY TRUST PLC (1.93M shares), CITADEL ADVISORS LLC (1.76M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.72M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.